Global Cardiac Biomarker Market Analysis 2016 - Forecast to 2022

  • ID: 3985557
  • Report
  • Region: Global
  • 148 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Cardiac Biomarker". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

- Market Sizing estimations and forecasts for 6 years across the given market segments
- Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping of major market players
- Company profiling covering the financials, recent activities and the future strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3.1 Market Analysis
3.2 Market Segmentation
3.3 Market Size Estimation
3.4 Market Drivers
3.5 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Cardiac Biomarkers Market, By Biomarkers Type
5.1 Introduction
5.2 Ischemia Modified Albumin
5.3 Natriuretic peptides (BNP and NT-proBNP)
5.4 Myoglobin
5.5 Troponins(T,I)
5.6 Hscrp
5.7 Creatine Kinase (CK-MB)
5.8 Other Biomarkers

6 Cardiac Biomarkers Market, By Product
6.1 Introduction
6.2 Reagents and Kits
6.3 Instruments
6.3.1 Immunochromatography
6.3.2 Chemiluminescence
6.3.3 Immunofluorescence
6.3.4 ELISA

7 Cardiac Biomarkers Market, By Application
7.1 Introduction
7.2 Atherosclerosis
7.3 Congestive Heart Failure
7.4 Myocardial Infarction
7.5 Acute Coronary Syndrome
7.6 Other Applications

8 Cardiac Biomarkers Market, By Type of Testing
8.1 Introduction
8.2 Point-Of-Care Testing
8.3 Laboratory Testing

9 Geographical Segmentation
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 RoW
9.4.1 Latin America
9.4.2 Middle East
9.4.3 Africa
9.4.4 Others

10 Vendor Landscaping
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Abbott Laboratories
11.1.1 Business Overview
11.1.2 SWOT Analysis
11.1.3 Financial Overview
11.1.4 Strategy
11.1.5 Key Activities
11.2 Alere Inc.
11.3 Beckman Coulter
11.4 Becton, Dickinson And Co.
11.5 Biomérieux SA
11.6 Bio-Rad Laboratories
11.7 Danaher Corporation
11.8 Guangzhou Wondfo Biotech Co., Ltd.
11.9 LSI Medience Corporation (A Subsidiary 0f Mitsubishi Chemical Holdings Corporation)
11.10 Ortho Clinical Diagnostics (A Subsidiary of the Carlyle Group)
11.11 Randox Laboratories Ltd.
11.12 Roche Diagnostics Limited (A Subsidiary of F. Hoffman-LA Roche Ltd.)
11.13 Siemens AG
11.14 Thermo Fisher Scientific
11.15 Signosis Inc.

12 Appendix
13 Disclaimer

List of Tables
1 Global Cardiac Biomarkers Market, By Region (2013-2022) ($MN)
2 Global Cardiac Biomarkers Market, By Biomarkers Type (2013-2022) ($MN)
3 Global Ischemia Modified Albumin Market, By Region (2013-2022) ($MN)
4 Global Natriuretic peptides (BNP and NT-proBNP) Market, By Region (2013-2022) ($MN)
5 Global Myoglobin Market, By Region (2013-2022) ($MN)
6 Global Troponins(T,I) Market, By Region (2013-2022) ($MN)
7 Global Hscrp Market, By Region (2013-2022) ($MN)
8 Global Creatine Kinase (CK-MB) Market, By Region (2013-2022) ($MN)
9 Global Other Biomarkers Market, By Region (2013-2022) ($MN)
10 Global Cardiac Biomarkers Market, By Product (2013-2022) ($MN)
11 Global Reagents and Kits Market, By Region (2013-2022) ($MN)
12 Global Instruments Market, By Region (2013-2022) ($MN)
13 Global Instruments Market, By Type (2013-2022) ($MN)
14 Global Cardiac Biomarkers Market, By Application (2013-2022) ($MN)
15 Global Atherosclerosis Market, By Region (2013-2022) ($MN)
16 Global Congestive Heart Failure Market, By Region (2013-2022) ($MN)
17 Global Myocardial Infarction Market, By Region (2013-2022) ($MN)
18 Global Acute Coronary Syndrome Market, By Region (2013-2022) ($MN)
19 Global Other Applications Market, By Region (2013-2022) ($MN)
20 Global Cardiac Biomarkers Market, By Type of Testing (2013-2022) ($MN)
21 Global Point-Of-Care Testing Market, By Region (2013-2022) ($MN)
22 Global Laboratory Testing Market, By Region (2013-2022) ($MN)
23 North America Cardiac Biomarkers Market, By Country (2013-2022) ($MN)
24 North America Cardiac Biomarkers Market, By Biomarkers Type (2013-2022) ($MN)
25 North America Ischemia Modified Albumin Market, By Country (2013-2022) ($MN)
26 North America Natriuretic peptides (BNP and NT-proBNP) Market, By Country (2013-2022) ($MN)
27 North America Myoglobin Market, By Country (2013-2022) ($MN)
28 North America Troponins(T,I) Market, By Country (2013-2022) ($MN)
29 North America Hscrp Market, By Country (2013-2022) ($MN)
30 North America Creatine Kinase (CK-MB) Market, By Country (2013-2022) ($MN)
31 North America Other Biomarkers Market, By Country (2013-2022) ($MN)
32 North America Cardiac Biomarkers Market, By Product (2013-2022) ($MN)
33 North America Reagents and Kits Market, By Country (2013-2022) ($MN)
34 North America Instruments Market, By Country (2013-2022) ($MN)
35 North America Instruments Market, By Type (2013-2022) ($MN)
36 North America Cardiac Biomarkers Market, By Application (2013-2022) ($MN)
37 North America Atherosclerosis Market, By Country (2013-2022) ($MN)
38 North America Congestive Heart Failure Market, By Country (2013-2022) ($MN)
39 North America Myocardial Infarction Market, By Country (2013-2022) ($MN)
40 North America Acute Coronary Syndrome Market, By Country (2013-2022) ($MN)
41 North America Other Applications Market, By Country (2013-2022) ($MN)
42 North America Cardiac Biomarkers Market, By Type of Testing (2013-2022) ($MN)
43 North America Point-Of-Care Testing Market, By Country (2013-2022) ($MN)
44 North America Laboratory Testing Market, By Country (2013-2022) ($MN)
45 Europe Cardiac Biomarkers Market, By Country (2013-2022) ($MN)
46 Europe Cardiac Biomarkers Market, By Biomarkers Type (2013-2022) ($MN)
47 Europe Ischemia Modified Albumin Market, By Country (2013-2022) ($MN)
48 Europe Natriuretic peptides (BNP and NT-proBNP) Market, By Country (2013-2022) ($MN)
49 Europe Myoglobin Market, By Country (2013-2022) ($MN)
50 Europe Troponins(T,I) Market, By Country (2013-2022) ($MN)
51 Europe Hscrp Market, By Country (2013-2022) ($MN)
52 Europe Creatine Kinase (CK-MB) Market, By Country (2013-2022) ($MN)
53 Europe Other Biomarkers Market, By Country (2013-2022) ($MN)
54 Europe Cardiac Biomarkers Market, By Product (2013-2022) ($MN)
55 Europe Reagents and Kits Market, By Country (2013-2022) ($MN)
56 Europe Instruments Market, By Country (2013-2022) ($MN)
57 Europe Instruments Market, By Type (2013-2022) ($MN)
58 Europe Cardiac Biomarkers Market, By Application (2013-2022) ($MN)
59 Europe Atherosclerosis Market, By Country (2013-2022) ($MN)
60 Europe Congestive Heart Failure Market, By Country (2013-2022) ($MN)
61 Europe Myocardial Infarction Market, By Country (2013-2022) ($MN)
62 Europe Acute Coronary Syndrome Market, By Country (2013-2022) ($MN)
63 Europe Other Applications Market, By Country (2013-2022) ($MN)
64 Europe Cardiac Biomarkers Market, By Type of Testing (2013-2022) ($MN)
65 Europe Point-Of-Care Testing Market, By Country (2013-2022) ($MN)
66 Europe Laboratory Testing Market, By Country (2013-2022) ($MN)
67 Asia Pacific Cardiac Biomarkers Market, By Country (2013-2022) ($MN)
68 Asia Pacific Cardiac Biomarkers Market, By Biomarkers Type (2013-2022) ($MN)
69 Asia Pacific Ischemia Modified Albumin Market, By Country (2013-2022) ($MN)
70 Asia Pacific Natriuretic peptides (BNP and NT-proBNP) Market, By Country (2013-2022) ($MN)
71 Asia Pacific Myoglobin Market, By Country (2013-2022) ($MN)
72 Asia Pacific Troponins(T,I) Market, By Country (2013-2022) ($MN)
73 Asia Pacific Hscrp Market, By Country (2013-2022) ($MN)
74 Asia Pacific Creatine Kinase (CK-MB) Market, By Country (2013-2022) ($MN)
75 Asia Pacific Other Biomarkers Market, By Country (2013-2022) ($MN)
76 Asia Pacific Cardiac Biomarkers Market, By Product (2013-2022) ($MN)
77 Asia Pacific Reagents and Kits Market, By Country (2013-2022) ($MN)
78 Asia Pacific Instruments Market, By Country (2013-2022) ($MN)
79 Asia Pacific Instruments Market, By Type (2013-2022) ($MN)
80 Asia Pacific Cardiac Biomarkers Market, By Application (2013-2022) ($MN)
81 Asia Pacific Atherosclerosis Market, By Country (2013-2022) ($MN)
82 Asia Pacific Congestive Heart Failure Market, By Country (2013-2022) ($MN)
83 Asia Pacific Myocardial Infarction Market, By Country (2013-2022) ($MN)
84 Asia Pacific Acute Coronary Syndrome Market, By Country (2013-2022) ($MN)
85 Asia Pacific Other Applications Market, By Country (2013-2022) ($MN)
86 Asia Pacific Cardiac Biomarkers Market, By Type of Testing (2013-2022) ($MN)
87 Asia Pacific Point-Of-Care Testing Market, By Country (2013-2022) ($MN)
88 Asia Pacific Laboratory Testing Market, By Country (2013-2022) ($MN)
89 RoW Cardiac Biomarkers Market, By Country (2013-2022) ($MN)
90 RoW Cardiac Biomarkers Market, By Biomarkers Type (2013-2022) ($MN)
91 RoW Ischemia Modified Albumin Market, By Country (2013-2022) ($MN)
92 RoW Natriuretic peptides (BNP and NT-proBNP) Market, By Country (2013-2022) ($MN)
93 RoW Myoglobin Market, By Country (2013-2022) ($MN)
94 RoW Troponins(T,I) Market, By Country (2013-2022) ($MN)
95 RoW Hscrp Market, By Country (2013-2022) ($MN)
96 RoW Creatine Kinase (CK-MB) Market, By Country (2013-2022) ($MN)
97 RoW Other Biomarkers Market, By Country (2013-2022) ($MN)
98 RoW Cardiac Biomarkers Market, By Product (2013-2022) ($MN)
99 RoW Reagents and Kits Market, By Country (2013-2022) ($MN)
100 RoW Instruments Market, By Country (2013-2022) ($MN)
101 RoW Instruments Market, By Type (2013-2022) ($MN)
102 RoW Cardiac Biomarkers Market, By Application (2013-2022) ($MN)
103 RoW Atherosclerosis Market, By Country (2013-2022) ($MN)
104 RoW Congestive Heart Failure Market, By Country (2013-2022) ($MN)
105 RoW Myocardial Infarction Market, By Country (2013-2022) ($MN)
106 RoW Acute Coronary Syndrome Market, By Country (2013-2022) ($MN)
107 RoW Other Applications Market, By Country (2013-2022) ($MN)
108 RoW Cardiac Biomarkers Market, By Type of Testing (2013-2022) ($MN)
109 RoW Point-Of-Care Testing Market, By Country (2013-2022) ($MN)
110 RoW Laboratory Testing Market, By Country (2013-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll